211 related articles for article (PubMed ID: 22072613)
21. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.
Wu F; Yao W; Yang J; Zhang M; Xu Y; Hao Y; Yan L; Niu Y; Sun T; Yu J; Zhou R
Biomed Pharmacother; 2017 Nov; 95():1161-1168. PubMed ID: 28926926
[TBL] [Abstract][Full Text] [Related]
22. Role of the RhoA/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs.
Lopez NC; Ebensperger G; Herrera EA; Reyes RV; Calaf G; Cabello G; Moraga FA; Beñaldo FA; Diaz M; Parer JT; Llanos AJ
Am J Physiol Regul Integr Comp Physiol; 2016 Jun; 310(11):R1053-63. PubMed ID: 26911462
[TBL] [Abstract][Full Text] [Related]
23. Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats.
Ho TJ; Huang CC; Huang CY; Lin WT
Eur J Appl Physiol; 2012 Aug; 112(8):2943-55. PubMed ID: 22160250
[TBL] [Abstract][Full Text] [Related]
24. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
Deng L; Li G; Li R; Liu Q; He Q; Zhang J
Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
[TBL] [Abstract][Full Text] [Related]
25. The RhoA/ROCK pathway mediates high glucose-induced cardiomyocyte apoptosis via oxidative stress, JNK, and p38MAPK pathways.
Zhou H; Sun Y; Zhang L; Kang W; Li N; Li Y
Diabetes Metab Res Rev; 2018 Sep; 34(6):e3022. PubMed ID: 29745021
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Rho-kinase Attenuates Left Ventricular Remodeling Caused by Chronic Intermittent Hypoxia in Rats via Suppressing Myocardial Inflammation and Apoptosis.
Wang ZH; Zhu D; Xie S; Deng Y; Pan Y; Ren J; Liu HG
J Cardiovasc Pharmacol; 2017 Aug; 70(2):102-109. PubMed ID: 28437280
[TBL] [Abstract][Full Text] [Related]
27. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts.
Zhou H; Zhang KX; Li YJ; Guo BY; Wang M; Wang M
Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):387-94. PubMed ID: 21457293
[TBL] [Abstract][Full Text] [Related]
28. [Expression and activity of RhoA/Rho kinase in remodeling of high blood flow pulmonary vessels.].
Li FH; Xia W; Sun RP
Zhonghua Er Ke Za Zhi; 2007 May; 45(5):387-92. PubMed ID: 17697629
[TBL] [Abstract][Full Text] [Related]
29. Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway.
Li JR; Zhao YS; Chang Y; Yang SC; Guo YJ; Ji ES
PLoS One; 2018; 13(4):e0195604. PubMed ID: 29641598
[TBL] [Abstract][Full Text] [Related]
30. Effects of ethanol on RhoA/Rho-kinase-mediated calcium sensitization in mouse lung parenchymal tissue.
Aydinoglu F; Ergurhan Kiroglu O; Astarci E; Balli E; Ogulener N
Eur J Pharmacol; 2015 Oct; 764():318-327. PubMed ID: 26169563
[TBL] [Abstract][Full Text] [Related]
31. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
[TBL] [Abstract][Full Text] [Related]
32. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
[TBL] [Abstract][Full Text] [Related]
33. Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina.
Kitaoka Y; Kitaoka Y; Kumai T; Lam TT; Kuribayashi K; Isenoumi K; Munemasa Y; Motoki M; Kobayashi S; Ueno S
Brain Res; 2004 Aug; 1018(1):111-8. PubMed ID: 15262212
[TBL] [Abstract][Full Text] [Related]
34. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
36. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
[TBL] [Abstract][Full Text] [Related]
37. A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate.
Baek I; Jeon SB; Kim J; Seok YM; Song MJ; Chae SC; Jun JE; Park WH; Kim IK
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):256-61. PubMed ID: 18986333
[TBL] [Abstract][Full Text] [Related]
38. Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model.
Park K; Kim SW; Rhu KS; Paick JS
J Sex Med; 2006 Nov; 3(6):996-1003. PubMed ID: 17100932
[TBL] [Abstract][Full Text] [Related]
39. A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat.
Sung JK; Miao L; Calvert JW; Huang L; Louis Harkey H; Zhang JH
Brain Res; 2003 Jan; 959(1):29-38. PubMed ID: 12480155
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
Ohta T; Takahashi T; Shibuya T; Amita M; Henmi N; Takahashi K; Kurachi H
Cancer Biol Ther; 2012 Jan; 13(1):25-33. PubMed ID: 22336585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
